<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02292381</url>
  </required_header>
  <id_info>
    <org_study_id>OPHT-250313</org_study_id>
    <nct_id>NCT02292381</nct_id>
  </id_info>
  <brief_title>Blood Flow Regulation in Glaucoma</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <brief_summary>
    <textblock>
      Glaucoma is one of the leading causes for blindness in industrialized countries. It is&#xD;
      characterized by a progressive loss of retinal ganglion cells, morphological changes in the&#xD;
      optic nerve head and a characteristic loss of visual field. Although increased intraocular&#xD;
      pressure has been identified as the major risk factor for the development and the progression&#xD;
      of the disease it has been speculated for a long time that impaired ocular blood flow may&#xD;
      contribute to the pathogenesis of the disease. This concept has been supported by several&#xD;
      epidemiological studies showing that low ocular perfusion pressure and small retinal vessel&#xD;
      caliber are associated with the disease.&#xD;
&#xD;
      The proposed study tests the hypothesis that patients with glaucoma have reduced total&#xD;
      retinal blood flow as compared to healthy subjects. Additionally, autoregulation of blood&#xD;
      flow will be investigated during an increase in ocular perfusion pressure. This is of&#xD;
      importance because it may clarify the degree of vascular involvement in glaucoma.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2014</start_date>
  <completion_date type="Actual">November 28, 2016</completion_date>
  <primary_completion_date type="Actual">November 28, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Optic nerve head blood flow</measure>
    <time_frame>once</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Retinal blood flow</measure>
    <time_frame>once</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Glaucoma Patients</arm_group_label>
    <description>Patients with primary open angle glaucoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <description>age- and sex matched controls</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Isometric exercise</intervention_name>
    <arm_group_label>Glaucoma Patients</arm_group_label>
    <arm_group_label>Healthy controls</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        60 open angle glaucoma patients 60 healthy age- and sex matched controls&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients with open angle glaucoma:&#xD;
&#xD;
        - Diagnosis of manifest open angle glaucoma as defined as pathological optic disc&#xD;
        appearance, glaucoma hemifield test outside normal limits and/or untreated intraocular&#xD;
        pressure â‰¥ 21 mmHg on at least three measurements in the medical history. Mean deviation in&#xD;
        the visual field test &lt; 10 decibel&#xD;
&#xD;
        Healthy control subjects:&#xD;
&#xD;
          -  normal ophthalmic findings and intraocular pressure &lt; 20 mmHg on at least three&#xD;
             measurements&#xD;
&#xD;
          -  no evidence of increased intraocular pressure in the medical history&#xD;
&#xD;
          -  no signs of glaucomatous damage in the optic disc or the glaucoma hemifield test&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence or history of a severe medical condition as judged by the investigator&#xD;
&#xD;
          -  Abuse of alcoholic beverages&#xD;
&#xD;
          -  Participation in a clinical trial in the 3 weeks preceding the study&#xD;
&#xD;
          -  Exfoliation glaucoma&#xD;
&#xD;
          -  Pigmentary glaucoma&#xD;
&#xD;
          -  Secondary glaucoma&#xD;
&#xD;
          -  Ocular hypertension&#xD;
&#xD;
          -  History of acute angle closure&#xD;
&#xD;
          -  Intraocular surgery within the last 6 months&#xD;
&#xD;
          -  History of epilepsia&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
          -  Ocular inflammation or infection within the last 3 months&#xD;
&#xD;
          -  Untreated hypertension with systolic blood pressure &gt;160 mmHg, diastolic blood&#xD;
             pressure &gt;95 mmHg&#xD;
&#xD;
          -  Pregnancy or lactating&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 22, 2013</study_first_submitted>
  <study_first_submitted_qc>November 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2014</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Gerhard Garhofer</investigator_full_name>
    <investigator_title>Assoc. Prof. Univ. Doz. Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

